Over the past 12 months, 14 insiders at Scholar Rock Holding Corp filed 48 open-market SEC Form 4 transactions on SRRK: 9 purchases worth $20.0M and 39 sales worth $16.6M. Insiders have been net sellers over this period. The most recent filing was on Jul 1, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 26 | Kristina Burow | SELL | 2.1K | $54.28 | $113K |
| Jul 1, 26 | Jeffrey S. Flier | SELL | 1.6K | $54.88 | $84K |
| Jul 1, 26 | Michael Gilman | SELL | 1.3K | $54.81 | $72K |
| Jul 1, 26 | Katie Peng | SELL | 3.0K | $54.96 | $160K |
| Jul 1, 26 | Joshua Reed | SELL | 2.1K | $54.28 | $113K |
| Feb 23, 26 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 7.4K | $48.48 | $349K |
| Feb 17, 26 | Junlin HoGENERAL COUNSEL | SELL | 9.6K | $46.53 | $446K |
| Feb 17, 26 | Jing L. MarantzCHIEF MEDICAL OFFICER | SELL | 4.2K | $46.53 | $193K |
| Feb 17, 26 | Caryn ParlavecchioCHRO | SELL | 9.0K | $46.53 | $420K |
| Feb 17, 26 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 8.0K | $46.53 | $372K |
| Jan 22, 26 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 12.8K | $46.85 | $599K |
| Jan 16, 26 | Junlin HoGENERAL COUNSEL | SELL | 8.0K | $44.48 | $357K |
| Jan 16, 26 | Jing L. MarantzCHIEF MEDICAL OFFICER | SELL | 5.8K | $44.48 | $258K |
| Jan 16, 26 | Caryn ParlavecchioCHRO | SELL | 6.6K | $44.48 | $294K |
| Jan 16, 26 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 8.4K | $44.48 | $374K |
| Jan 14, 26 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 13.1K | $45.20 | $593K |
| Jan 13, 26 | David HallalChief Executive Officer | SELL | 57.5K | $42.70 | $2.5M |
| Jan 13, 26 | Vikas SinhaChief Financial Officer | SELL | 16.8K | $42.70 | $715K |
| Jan 13, 26 | Akshay VaishnawPresident of R&D | SELL | 20.4K | $42.70 | $873K |
| Jan 13, 26 | Keith WoodsChief Operating Officer | SELL | 16.7K | $42.70 | $715K |
| Dec 16, 25 | Katie PengDirector | SELL | 726 | $44.63 | $32K |
| Dec 4, 25 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 136.5K | $45.21 | $6.2M |
| Oct 7, 25 | Srinivas AkkarajuDirector | BUY | 12.8K | $40.97 | $503K |
| Oct 6, 25 | Srinivas AkkarajuDirector | BUY | 80.9K | $39.52 | $3.1M |
| Oct 3, 25 | Srinivas AkkarajuDirector | BUY | 319.7K | $37.42 | $12.0M |
| Sep 22, 25 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 3.4K | $30.67 | $103K |
| Sep 16, 25 | Katie PengDirector | SELL | 930 | $33.20 | $30K |
| Sep 16, 25 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 3.2K | $33.52 | $107K |
| Aug 18, 25 | Caryn ParlavecchioCHRO | SELL | 2.2K | $31.17 | $68K |
| Jul 16, 25 | Jeffrey S. FlierDirector | SELL | 11.1K | $40.02 | $446K |
| Jul 8, 25 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 24.1K | $34.44 | $829K |
| Jun 23, 25 | Jeffrey S. FlierDirector | SELL | 17.6K | $33.21 | $564K |
| Jun 16, 25 | Junlin HoGENERAL COUNSEL | SELL | 7.4K | $32.00 | $238K |
| Jun 16, 25 | Caryn ParlavecchioCHRO | SELL | 6.2K | $32.00 | $198K |
| Jun 16, 25 | Katie PengDirector | SELL | 3.0K | $32.53 | $95K |
| Jun 16, 25 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 3.7K | $32.00 | $117K |
| May 29, 25 | Richard BrudnickDirector | SELL | 4.7K | $30.00 | $139K |
| May 29, 25 | Kristina BurowDirector | SELL | 4.4K | $29.83 | $131K |
| May 29, 25 | Jeffrey S. FlierDirector | SELL | 5.0K | $29.84 | $148K |
| May 29, 25 | Michael GilmanDirector | SELL | 2.7K | $29.83 | $82K |
| May 29, 25 | Joshua ReedDirector | SELL | 4.9K | $30.04 | $145K |
| May 29, 25 | Akshay VaishnawPresident of R&D | SELL | 5.1K | $30.01 | $152K |
| Apr 25, 25 | Tracey SaccoChief Commercial Officer | SELL | 4.9K | $33.49 | $161K |
| Mar 24, 25 | Erin MooreInterim PFO and PAO | SELL | 13.6K | $33.12 | $449K |
| Mar 24, 25 | Tracey SaccoChief Commercial Officer | SELL | 5.0K | $33.70 | $164K |
| Mar 17, 25 | Katie PengDirector | SELL | 1.0K | $34.42 | $35K |
| Mar 10, 25 | Edward H MylesCOO & CFO | SELL | 112.9K | $35.82 | $4.0M |
| Feb 19, 25 | Mo QatananiCHIEF SCIENTIFIC OFFICER | SELL | 40.0K | $37.74 | $1.5M |
| Feb 18, 25 | Jay T. BackstromCHIEF EXECUTIVE OFFICER | SELL | 18.4K | $36.83 | $677K |
| Feb 18, 25 | Junlin HoGENERAL COUNSEL | SELL | 5.7K | $36.83 | $211K |
Over the past 12 months, insiders at Scholar Rock Holding Corp filed 9 open-market purchases worth $20.0M and 39 sales worth $16.6M on SRRK, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 1, 26.
The largest recent open-market SRRK insider purchase in our data was $12.0M by Srinivas Akkaraju, Director, filed on Oct 3, 25.
14 different insiders at Scholar Rock Holding Corp filed open-market SEC Form 4 transactions on SRRK over the last 12 months.
InsiderTape plots every SRRK insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Scholar Rock Holding Corp insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →